SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma.
Zhang X, Duan YT, Wang Y, Zhao XD, Sun YM, Lin DZ, Chen Y, Wang YX, Zhou ZW, Liu YX, Jiang LH, Geng MY, Ding J, Meng LH.
Zhang X, et al. Among authors: chen y.
Acta Pharmacol Sin. 2022 Jan;43(1):209-219. doi: 10.1038/s41401-021-00644-1. Epub 2021 Mar 29.
Acta Pharmacol Sin. 2022.
PMID: 33782541
Free PMC article.